Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prostacyclin measurement |
Has measured component |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Prostacyclin measurement |
Component |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Product containing prostacyclin PGI2 (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Product containing epoprostenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Product containing iloprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
iloprost 100 µg/ml koncentrat til infusionsvæske, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
epoprostenol 500 µg pulver og solvent til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
iloprost 10 µg/ml inhalationsvæske til nebulisator, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
epoprostenol 1,5 mg pulver og solvent til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Epoprostenol sodium 1.5mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Epoprostenol sodium 0.5mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Prostacyclin PGI2 (substance) |
Is a |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|